Harnessing vaccine technology to heal bone

ROCHESTER, Minn. ― Although fractures normally heal, bone will not regenerate under several circumstances. When bone does not regenerate, major clinical problems could result, including amputation. To enhance the regeneration of bone, the Food and Drug Administration (FDA) approved recombinant human bone morphogen etic protein-2, or BMP-2. However, it is expensive and only moderately effective. It also produces side effects ― some severe. Researchers at Mayo Clinic, along with colleagues in the Netherlands and Germany, may…
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news